Immunoglobulin Market to Grow at 5.4% CAGR by 2030

Increasing geriatric population along with improved immunoglobulin production are key factors driving the growth of the immunoglobulin market.

The Immunoglobulin Market is expected to grow at a CAGR of 5.4% from 2020-2030, according to a new research report by Next Move Strategy Consulting.

Immunoglobulins are produced by plasma cells and other lymphocyte to protect the body from diseases. They act as antibodies and support the immune system against viruses, bacteria and other disease causing agents. The growth of the immunoglobulin market is majorly driven by factors such as increasing geriatric population and rising number of hemophilic patients. Also, improved production of immunoglobulins due to the adoption of advanced technology for the extraction and introduction of enhanced purification processes in recent times, has been significantly contributing to the growth of the immunoglobulin market. However, strict government policies along with risk of side effects are anticipated to hinder the market growth during the forecast period to some extent.

On the basis of product, the market is segmented into IGG, IGA, IGM, IGE and IGD. On the basis of application, the market is segmented into Hypogammaglobulinemia, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Immunodeficiency Disease, Myasthenia Gravis, Multifocal Motor Neuropathy, Idiopathic Thrombocytopenic Purpura (ITP), Inflammatory Myopathies, Specific Antibody Deficiency, Guillain Barre Syndrome, and Others. On the basis of mode of delivery, the market is segmented into intravenous and subcutaneous. Intravenous is sub segmented into 5% concentration, 10% concentration and others. Subcutaneous is sub segmented into 16.5% concentration, 20% concentration and others. Based on geography the market is segmented into North America, Europe, Asia Pacific and RoW.

Geographically, North America holds the lion share of the global immunoglobulin market owing to factors such as presence of developed economies as well as increasing prevalence of haemophilia in this region. However, Asia Pacific is expected to show exponential growth within the forecast period. This is attributed to factors such as rising geriatric population, prevalence of inflammatory diseases, and increasing accessibility to healthcare facilities in this region.

Browse key industry insight  in the report, “Immunoglobulin Market by Product (IGG, IGA, IGM, IGE, and IGD), by Application (Hypogammaglobulinemia, Chronic Inflammatory Demyelinating Polyneuropathy, Immunodeficiency Disease, Myasthenia Gravis, Multifocal Motor Neuropathy, Idiopathic Thrombocytopenic Purpura, Inflammatory Myopathies, Specific Antibody Deficiency, Guillain-Barre Syndrome, and Others), and by Mode of Delivery (Intravenous and Subcutaneous): Global Opportunity Analysis and Industry Forecast, 2020-2030”

According to the report, some the key players in the immunoglobulin market are CSL Ltd., Baxter international Inc., Octapharma AG, Grifols S.A, LFB group, Kedrion Biopharma Inc., China Biologics Products, Inc., Biotest AG, Shire (Baxalta), and Bayer AG among others.

Key Insights from the Immunoglobulin Market Report:

• Current emerging trends and opportunities are extensively analysed in immunoglobulin market report.

• The forecast of the immunoglobulin market comes along with additional information associated with opportunities, restrains and key drivers in the market.

The report Immunoglobulin Market – is segmented by product, application, mode of delivery and geography.

Get a free sample on the Immunoglobulin Market report

About Next Move Strategy Consulting

Next Move Strategy Consulting is an independent and trusted third-platform market intelligence provider, committed to deliver high quality, market research reports that help multinational companies to triumph over their competitions and increase industry footprint by capturing greater market share. Our research model is a unique collaboration of primary research, secondary research, data mining and data analytics.

We have been servicing over 1000 customers globally that includes 90% of the Fortune 500 companies over a decade. Our analysts are constantly tracking various high growth markets and identifying hidden opportunities in each sector or the industry. We provide one of the industry’s best quality syndicate as well as custom research reports across 10 different industry verticals. We are committed to deliver high quality research solutions in accordance to your business needs. Our industry standard delivery solutions that ranges from the pre consultation to after-sales services, provide an excellent client experience and ensure right strategic decision making for businesses.

For more insights, please visit, https://www.nextmsc.com

Share this post?